Detalhe da pesquisa
1.
FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies.
Genet Med
; 25(2): 100335, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507973
2.
African American patients with gout: efficacy and safety of febuxostat vs allopurinol.
BMC Musculoskelet Disord
; 13: 15, 2012 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22316106
3.
Stage-specific cancer incidence: an artificially mixed multinomial logit model.
Stat Med
; 28(15): 2054-76, 2009 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19452568
4.
Generalized Self-Consistency: Multinomial logit model and Poisson likelihood.
J Stat Plan Inference
; 138(8): 23802397, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18709183
5.
The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength.
Bone
; 41(5): 804-12, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17825637
6.
Preservation of renal function during gout treatment with febuxostat: a quantitative study.
Postgrad Med
; 125(1): 106-14, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23391676
7.
Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.
Clin J Am Soc Nephrol
; 8(11): 1960-7, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23929928
8.
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Arthritis Care Res (Hoboken)
; 64(2): 256-61, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22052584